Copyright Reports & Markets. All rights reserved.

Global Topical Recombinant Human Thrombin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Capacity
    • 1.3.1 Overview: Global Topical Recombinant Human Thrombin Consumption Value by Capacity: 2021 Versus 2025 Versus 2032
    • 1.3.2 2000/Bottle
    • 1.3.3 5000/Bottle
    • 1.3.4 Others
  • 1.4 Market Analysis by Solvent
    • 1.4.1 Overview: Global Topical Recombinant Human Thrombin Consumption Value by Solvent: 2021 Versus 2025 Versus 2032
    • 1.4.2 Lyophilized Powder
    • 1.4.3 Ready to Use Solution
  • 1.5 Market Analysis by Use
    • 1.5.1 Overview: Global Topical Recombinant Human Thrombin Consumption Value by Use: 2021 Versus 2025 Versus 2032
    • 1.5.2 Direct External Use
    • 1.5.3 Carrier Composite External Use
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Topical Recombinant Human Thrombin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Clinic
  • 1.7 Global Topical Recombinant Human Thrombin Market Size & Forecast
    • 1.7.1 Global Topical Recombinant Human Thrombin Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Topical Recombinant Human Thrombin Sales Quantity (2021-2032)
    • 1.7.3 Global Topical Recombinant Human Thrombin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Baxter
    • 2.1.1 Baxter Details
    • 2.1.2 Baxter Major Business
    • 2.1.3 Baxter Topical Recombinant Human Thrombin Product and Services
    • 2.1.4 Baxter Topical Recombinant Human Thrombin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Baxter Recent Developments/Updates
  • 2.2 Suzhou Zelgen Biopharmaceuticals
    • 2.2.1 Suzhou Zelgen Biopharmaceuticals Details
    • 2.2.2 Suzhou Zelgen Biopharmaceuticals Major Business
    • 2.2.3 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Product and Services
    • 2.2.4 Suzhou Zelgen Biopharmaceuticals Topical Recombinant Human Thrombin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Topical Recombinant Human Thrombin by Manufacturer

  • 3.1 Global Topical Recombinant Human Thrombin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Topical Recombinant Human Thrombin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Topical Recombinant Human Thrombin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Topical Recombinant Human Thrombin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Topical Recombinant Human Thrombin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Topical Recombinant Human Thrombin Manufacturer Market Share in 2025
  • 3.5 Topical Recombinant Human Thrombin Market: Overall Company Footprint Analysis
    • 3.5.1 Topical Recombinant Human Thrombin Market: Region Footprint
    • 3.5.2 Topical Recombinant Human Thrombin Market: Company Product Type Footprint
    • 3.5.3 Topical Recombinant Human Thrombin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Topical Recombinant Human Thrombin Market Size by Region
    • 4.1.1 Global Topical Recombinant Human Thrombin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Topical Recombinant Human Thrombin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Topical Recombinant Human Thrombin Average Price by Region (2021-2032)
  • 4.2 North America Topical Recombinant Human Thrombin Consumption Value (2021-2032)
  • 4.3 Europe Topical Recombinant Human Thrombin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Topical Recombinant Human Thrombin Consumption Value (2021-2032)
  • 4.5 South America Topical Recombinant Human Thrombin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Topical Recombinant Human Thrombin Consumption Value (2021-2032)

5 Market Segment by Capacity

  • 5.1 Global Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 5.2 Global Topical Recombinant Human Thrombin Consumption Value by Capacity (2021-2032)
  • 5.3 Global Topical Recombinant Human Thrombin Average Price by Capacity (2021-2032)

6 Market Segment by Application

  • 6.1 Global Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 6.2 Global Topical Recombinant Human Thrombin Consumption Value by Application (2021-2032)
  • 6.3 Global Topical Recombinant Human Thrombin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 7.2 North America Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 7.3 North America Topical Recombinant Human Thrombin Market Size by Country
    • 7.3.1 North America Topical Recombinant Human Thrombin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Topical Recombinant Human Thrombin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 8.2 Europe Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Topical Recombinant Human Thrombin Market Size by Country
    • 8.3.1 Europe Topical Recombinant Human Thrombin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Topical Recombinant Human Thrombin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 9.2 Asia-Pacific Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Topical Recombinant Human Thrombin Market Size by Region
    • 9.3.1 Asia-Pacific Topical Recombinant Human Thrombin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Topical Recombinant Human Thrombin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 10.2 South America Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 10.3 South America Topical Recombinant Human Thrombin Market Size by Country
    • 10.3.1 South America Topical Recombinant Human Thrombin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Topical Recombinant Human Thrombin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Topical Recombinant Human Thrombin Sales Quantity by Capacity (2021-2032)
  • 11.2 Middle East & Africa Topical Recombinant Human Thrombin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Topical Recombinant Human Thrombin Market Size by Country
    • 11.3.1 Middle East & Africa Topical Recombinant Human Thrombin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Topical Recombinant Human Thrombin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Topical Recombinant Human Thrombin Market Drivers
  • 12.2 Topical Recombinant Human Thrombin Market Restraints
  • 12.3 Topical Recombinant Human Thrombin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Topical Recombinant Human Thrombin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Topical Recombinant Human Thrombin
  • 13.3 Topical Recombinant Human Thrombin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Topical Recombinant Human Thrombin Typical Distributors
  • 14.3 Topical Recombinant Human Thrombin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Topical Recombinant Human Thrombin market size was valued at US$ 256 million in 2025 and is forecast to a readjusted size of US$ 448 million by 2032 with a CAGR of 8.3% during review period.
    n 2025, global topical recombinant human thrombin production reached approximately 230 k units, the average price is 1080 usd/unit. Topical recombinant human thrombin is a topical thrombin used when capillaries and venules oozing blood and minor bleeding are available and the bleeding is controlled by standard surgical techniques such as sutures, ligation, or cautery. When ineffective or impractical in the population, it can assist in hemostasis.
    Market Concentration and Key Players:
    Internationally, the market concentration of recombinant human thrombin for external use is relatively high, mainly concentrated in developed countries such as Europe, America and Japan. From the domestic point of view, recombinant human thrombin for external use still has a lot of room for development.
    Manufacturing Processes and Market Trends:
    The core of the preparation process of recombinant human thrombin for external use lies in gene recombination and cell culture technology. The gene encoding human thrombin is introduced into CHO cells and other expression systems, and high-purity products are obtained through multi-step precise procedures such as cell culture, amplification, centrifugal filtration and chromatography purification. The whole process avoids the dependence of the traditional process on human plasma. Compared with thrombin derived from human or animal blood, recombinant products significantly reduce the risk of viral contamination and immunogenicity while achieving comparable hemostatic effects, and are easier to achieve large-scale, cost-controlled production.
    At the market level, the demand for recombinant human thrombin for external use in China is closely linked to the steady growth of surgical volume, driving the expansion of the surgical local hemostatic drug market. Recombinant human thrombin has great market potential because of its high safety and relatively low cost. At present, there are few products that have been marketed worldwide. Zejing Pharmaceutical is a leading enterprise in this field in China. Its self-developed recombinant human thrombin for external use has submitted a marketing authorization application, filling the gap in the domestic market.
    Future trends focus on technical iterations to further improve the biological potency and purity of products, and explore the application potential in special environments such as wet or hypothermia, while developing new formulations combined with degradable biomaterials is also an important direction. Driven by both policy support for domestic innovative drugs and market demand, recombinant human thrombin for external use is expected to gradually replace traditional blood-derived products and become an important choice for surgical local hemostasis.
    This report is a detailed and comprehensive analysis for global Topical Recombinant Human Thrombin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Capacity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Topical Recombinant Human Thrombin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Topical Recombinant Human Thrombin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Topical Recombinant Human Thrombin market size and forecasts, by Capacity and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Topical Recombinant Human Thrombin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Topical Recombinant Human Thrombin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Topical Recombinant Human Thrombin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Suzhou Zelgen Biopharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Topical Recombinant Human Thrombin market is split by Capacity and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Capacity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Capacity
    2000/Bottle
    5000/Bottle
    Others
    Market segment by Solvent
    Lyophilized Powder
    Ready to Use Solution
    Market segment by Use
    Direct External Use
    Carrier Composite External Use
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Baxter
    Suzhou Zelgen Biopharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Topical Recombinant Human Thrombin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Topical Recombinant Human Thrombin, with price, sales quantity, revenue, and global market share of Topical Recombinant Human Thrombin from 2021 to 2026.
    Chapter 3, the Topical Recombinant Human Thrombin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Topical Recombinant Human Thrombin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Capacity and by Application, with sales market share and growth rate by Capacity, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Topical Recombinant Human Thrombin market forecast, by regions, by Capacity, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Topical Recombinant Human Thrombin.
    Chapter 14 and 15, to describe Topical Recombinant Human Thrombin sales channel, distributors, customers, research findings and conclusion.

    Buy now